生物技术公司Aardvark Therapeutics(股票代码为：“AARD”）昨日在美国纳斯达克上市。 Aardvark Therapeutics发行价为16美元，发行588.8万股，募资总额为9421万 ...

Aardvark Therapeutics ... Graf, RPh, MBA to its Board of Directors. Dr. Baynes was previously Chief Medical Officer and head of clinical development at Merck. Ms. Graf is currently a senior ...

(Aardvark), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today ...